BUY Grasim Industries Limited — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Intraday)29 Jul 2026, 9:58 am ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · adjacent horizon·17 Jul · 2w ago
Nothing found in this tip’s window yet.
Grasim Industries Slides 2% Despite Q4 Profit Growth
NewsGoogle News·23 Jul · 5d ago
Grasim Industries Share Price: லாபம் 61% உயர்ந்தும் பங்குகள் 2% சரிவு! காரணம் என்ன?
NewsGoogle News·23 Jul · 5d ago
Grasim Industries: Q4 ਵਿੱਚ ਮੁਨਾਫ਼ਾ ਵਧਣ ਦੇ ਬਾਵਜੂਦ ਸ਼ੇਅਰਾਂ ਵਿੱਚ ਗਿਰਾਵਟ
NewsGoogle News·23 Jul · 5d ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Grasim Industries
- BUY — Sumeet Bagadia, Choice Broking19 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- BUY — Sandeep Jain, Tradeswift19 Oct 2026 · Same day · target ₹2,990 · SL hit
- BUY — Sumeet Bagadia, Choice Broking17 Oct 2026 · ~2 weeks · target ₹3,240 · Active
- BUY — Sumeet Bagadia, Choice Broking24 Sept 2026 · Same day · target ₹3,250 · Expired
- SELL — Rakesh Bansal17 Sept 2026 · Next day · target ₹3,100 · Expired
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

